CLBT
Cellebrite DI Ltd.
CLBT has lower modeled downside risk, despite its lower overall score.
SNDK
Sandisk Corporation
SNDK has the edge over CLBT overall, supported by stronger fundamentals and stronger modeled upside.
CLBT Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Stable | |
| Strong | |
| Strong |
CLBT's revenue, cash flow and balance sheet are currently healthy, and its profitability is stable.
SNDK Fundamentals
| Metric | Status |
|---|---|
| Strong | |
| Strong | |
| Strong | |
| Strong |
SNDK's revenue, profitability, cash flow and balance sheet are all currently strong.
CLBT PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 7.1x | $1.64 | -85% |
| Forward | 33x | $10.89 | — |
| Fair | 44x | $10.10 | -7.3% |
| Current | 47x | $10.89 | — |
| Expensive | 62x | $14.35 | +32% |
Historical ranges are pointers, not guarantees.
CLBT's PE is in its fair range at 47x, but its recent earnings include one-off gains. If earnings grow as analysts expect, today's price would be 33x next year's earnings.
SNDK PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 3.8x | $937 | — |
| Current | 7.5x | $937 | — |
| Cheap | 17x | $2,173 | +132% |
| Fair | 24x | $3,048 | +225% |
| Expensive | 59x | $7,452 | +695% |
Historical ranges are pointers, not guarantees.
SNDK has the edge over CLBT in the historical PE scenario, which offers more potential upside but is not a forecast.
CLBT Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Growth | |
| Growth | |
| Weakening | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for CLBT, but weaker profitability.
SNDK Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Strong growth | |
| Strong growth | |
| Strongly improving | |
| Moderate | |
| High |
SNDK has the edge over CLBT on the outlook, with more favorable profitability expectations.
CLBT Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.33 | +46% |
| Q2 2026 | $0.23 | +$0.99 |
| Q1 2026 | $0.29 | +$1.25 |
| Q4 2025 | $0.31 | +$1.70 |
| Q3 2025 | $0.31 | +$1.86 |
| Q2 2025 | -$0.76 | -$0.24 |
| Q1 2025 | -$0.96 | -$0.39 |
| Q4 2024 | -$1.39 | -$0.96 |
| Q3 2024 | -$1.55 | -$1.23 |
CLBT has returned to profit: it earned $0.23 per share over the past year, after losing money the year before. Its recent earnings include one-off gains.
SNDK Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $247.30 | +97% |
| Q3 2026 | $125.61 | +$137.63 |
| Q2 2026 | $73.76 | +$85.07 |
| Q2 2025 | -$11.31 | -$6.65 |
SNDK has the edge over CLBT in the latest year-over-year earnings comparison.
CLBT Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $131.1M | +16% |
| Q1 2026 | $128.3M | +19% |
| Q4 2025 | $128.8M | +18% |
| Q3 2025 | $126M | +18% |
| Q2 2025 | $113.3M | +18% |
| Q1 2025 | $107.5M | +20% |
| Q4 2024 | $109M | +17% |
| Q3 2024 | $106.9M | +27% |
CLBT's revenue has grown year over year every quarter since early 2021: $131M last quarter, up 16% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 5.8% | -6.9 points |
| Q1 2026 | 7.1% | -4.3 points |
| Q4 2025 | 16% | +1.7 points |
| Q3 2025 | 15% | -3.1 points |
| Q2 2025 | 13% | -0.3 points |
| Q1 2025 | 11% | +1.1 points |
| Q4 2024 | 14% | -1.7 points |
| Q3 2024 | 18% | +2.2 points |
CLBT's operating margin was 5.8% last quarter, down 6.9 points from the same quarter a year ago.
SNDK Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $11B | +378% |
| Q2 2026 | $9B | +372% |
| Q1 2026 | $6B | +251% |
| Q4 2025 | $3B | +61% |
| Q3 2025 | $2.3B | +23% |
| Q2 2025 | $1.9B | +8% |
| Q1 2025 | $1.7B | -0.6% |
| Q4 2024 | $1.9B | +13% |
SNDK's revenue has grown year over year for six quarters in a row: $11B last quarter, up 378% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 80% | +72 points |
| Q2 2026 | 78% | +78 points |
| Q1 2026 | 69% | +180 points |
| Q4 2025 | 35% | +25 points |
| Q3 2025 | 7.6% | -9 points |
| Q2 2025 | 0.9% | N/A |
| Q1 2025 | -111% | -122 points |
| Q4 2024 | 10% | +6.6 points |
SNDK has the edge over CLBT on profitability, with a higher operating margin.
CLBT Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $14.5M | -50% |
| Q1 2026 | $16.8M | -9.1% |
| Q4 2025 | $78.3M | +27% |
| Q3 2025 | $30M | -25% |
| Q2 2025 | $29M | +138% |
| Q1 2025 | $18.5M | +134% |
| Q4 2024 | $61.7M | +59% |
| Q3 2024 | $39.8M | +42% |
CLBT generated $140M in free cash flow over the past year, down 6.3% from the year before.
SNDK Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $6.3B | +1340% |
| Q2 2026 | $7.1B | +14355% |
| Q1 2026 | $3B | +$3B |
| Q3 2025 | $438M | +$636M |
| Q2 2025 | $49M | +$217M |
| Q1 2025 | -$18M | +$23M |
| Q3 2024 | -$198M | -$157M |
SNDK has the edge over CLBT on cash flow, with more consistent year-over-year improvement.
CLBT Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.3% | +711K shares |
| 1 year | +1.5% | +3.8M shares |
| 3 years | +34% | +64.7M shares |
| 5 years | +35% | +65.6M shares |
| Available history | +35% | +65.6M shares |
CLBT has the edge over SNDK on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | $11,000 |
CLBT hasn't bought back shares in the past year.
SNDK Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -0.6% | -1M shares |
| 1 year | +3.4% | +5M shares |
| 3 years | +6.9% | +10M shares |
SNDK has 154M diluted shares, up 3.4% from a year ago.
| Quarter | Spent |
|---|---|
| Q3 2026 | $5B |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
CLBT Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | -1.0x | Net Cash |
| Q1 2026 | -0.9x | Net Cash |
| Q4 2025 | -0.8x | Net Cash |
| Q3 2023 | -0.8x | Net Cash |
| Q2 2023 | -0.6x | Net Cash |
| Q1 2023 | -0.4x | Net Cash |
| Q4 2022 | -0.3x | Net Cash |
| Q3 2022 | -0.4x | Net Cash |
CLBT has the edge over SNDK on leverage, with a lower net debt burden relative to earnings.
SNDK Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -0.2x | Net Cash |
| Q2 2026 | -0.4x | Net Cash |
| Q1 2026 | -0.7x | Net Cash |
SNDK has more cash than debt.
CLBT Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 41.7 | Neutral |
| Stochastic | 32.9 | Neutral |
CLBT's weekly RSI is 42 (neutral) and its Stochastic is 33 (neutral).
SNDK Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 40.2 | Neutral |
| Stochastic | 10.6 | Oversold |
SNDK's weekly RSI is 40 (neutral) and its Stochastic is 11 (oversold).
CLBT PE vs Technology Sector
| Metric | CLBT | Sector median | Relative |
|---|---|---|---|
| PE | 47x | 28x | 67% above |
| PE % | 55 | 39 | 16 pts above |
CLBT is trading at 47x earnings, a 67% premium to the Technology sector's median of 28x, though its recent earnings include one-off gains.
SNDK PE vs Technology Sector
| Metric | SNDK | Sector median | Relative |
|---|---|---|---|
| PE | 7.5x | 28x | 73% below |
| PE % | 4 | 27 | 23 pts below |
SNDK has the edge over CLBT on valuation relative to its sector.
CLBT Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $11.5 | 5.1% below |
| 20 week MA | $12.6 | 14% below |
| 50 week MA | $13.9 | 22% below |
| 100 week MA | $16.1 | 32% below |
| 200 week MA | $13.1 | 17% below |
SNDK has stronger trend alignment. CLBT is above 0 of 5 weekly averages versus SNDK above 0 of 3.
SNDK Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $1,317.5 | 29% below |
| 20 week MA | $1,465.4 | 36% below |
| 50 week MA | $1,119.6 | 16% below |
SNDK is in a downtrend: it's below all three of its weekly moving averages, and 16% below its 50-week average.
CLBT Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.66 | $10.5 | +8.8% |
| 2021 | $10.5 | $8.10 | -23% |
| 2022 | $8.10 | $4.18 | -48% |
| 2023 | $4.18 | $8.66 | +107% |
| 2024 | $8.66 | $22.2 | +156% |
| 2025 | $22.2 | $18.4 | -17% |
| 2026 YTD | $18.4 | $10.9 | -41% |
CLBT's yearly returns have swung widely, from +156% in 2024 to −48% in 2022. It's down 41% so far in 2026.
SNDK Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2025 | $50.4 | $250.1 | +396% |
| 2026 YTD | $250.1 | $937.5 | +275% |
SNDK has the edge over CLBT on returns for 2026, with the stronger performance.